A New Alzheimer’s Drug May Be the Most Effective One Yet
July 02, 2024 at 20:44 PM EDT
On July 2, the U.S. Food and Drug Administration (FDA) approved a new drug for treating Alzheimer’s disease. Donanemab, or Kisunla, is the third drug approved to target one of the causes of Alzheimer’s: the buildup of amyloid protein in the brain. Based on the data provided by the drug's … Source
